Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Circulating Vascular Regenerative Cell Exhaustion in Individuals without Type 2 Diabetes who are of South Asian or European Origins
FY 2024-25
Summary
Cardiovascular diseases (CVD), such as heart attack and stroke, is the main cause of death worldwide. The risk of developing CVD is increased by risk factors such as type 2 diabetes (T2D) and varies between different ethnic groups. Notably, people of South Asian (SA) origin represent 25% of the world population, yet account for over 50% of global CVD deaths. Understanding the causes of elevated CVD risk in SA individuals is vital for the development of personalized CVD treatments for Canadians of SA origin. Cardiovascular health is maintained by blood vessel repair and regeneration, driven by vascular regenerative (VR) stem cells made in the bone marrow that travel through the blood to sites of vessel damage. Our lab developed a new method to count circulating VR stem cells using patient blood samples. We previously showed that SA adults with T2D or CVD show vascular regenerative cell exhaustion (VRCE), denoted by less VR cells compared to White European (WE) adults with T2D or CVD. However, it is unclear whether VRCE only occurs in people with T2D and CVD, or if it is a common trait in healthy SA individuals. This study aims to count the number of VR stem cells in SA vs WE adults without T2D or CVD. We hypothesize that SA adults will have less circulating VR stem cells, and with reduced vessel-repairing capacity, compared to WE adults. We will enroll 60 SA and 60 WE adults, with 30 males and 30 female participants in each group. Blood samples will be collected, and VR cell counts will be measured using our flow cytometry protocol. Determining baseline VRCE in SA individuals at higher risk of developing CVD will establish our VRCE protocol as a new indicator of CVD risk. This may also allow for tailored treatment strategies for SA individuals worldwide.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530053
Name
He Arianna Z
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Circulating Vascular Regenerative Cell Exhaustion in Individuals without Type 2 Diabetes who are of South Asian or European Origins
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular System; Ethnicity; Flow Cytometry; Granulocytes; Hematopoietic Progenitor Cells; Inflammation; Monocytes; South Asian; Vascular Regeneration; White European
Abstract
Cardiovascular diseases (CVD), such as heart attack and stroke, is the main cause of death worldwide. The risk of developing CVD is increased by risk factors such as type 2 diabetes (T2D) and varies between different ethnic groups. Notably, people of South Asian (SA) origin represent 25% of the world population, yet account for over 50% of global CVD deaths. Understanding the causes of elevated CVD risk in SA individuals is vital for the development of personalized CVD treatments for Canadians of SA origin. Cardiovascular health is maintained by blood vessel repair and regeneration, driven by vascular regenerative (VR) stem cells made in the bone marrow that travel through the blood to sites of vessel damage. Our lab developed a new method to count circulating VR stem cells using patient blood samples. We previously showed that SA adults with T2D or CVD show vascular regenerative cell exhaustion (VRCE), denoted by less VR cells compared to White European (WE) adults with T2D or CVD. However, it is unclear whether VRCE only occurs in people with T2D and CVD, or if it is a common trait in healthy SA individuals. This study aims to count the number of VR stem cells in SA vs WE adults without T2D or CVD. We hypothesize that SA adults will have less circulating VR stem cells, and with reduced vessel-repairing capacity, compared to WE adults. We will enroll 60 SA and 60 WE adults, with 30 males and 30 female participants in each group. Blood samples will be collected, and VR cell counts will be measured using our flow cytometry protocol. Determining baseline VRCE in SA individuals at higher risk of developing CVD will establish our VRCE protocol as a new indicator of CVD risk. This may also allow for tailored treatment strategies for SA individuals worldwide.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
He, Arianna Z
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~